Inquest into the death of DB, JD, DC, RG, AH, AB
Date of death
2016-05
Finding date
2019-03-01
Cause of death
multi-drug toxicity (opioids, heroin, benzodiazepines, prescription drugs)
AI-generated summary
This inquest examined six opioid-related deaths in NSW occurring in May 2016, with causes ranging from heroin and fentanyl toxicity to multi-drug overdoses. The coroner identified multiple preventable factors: inadequate treatment capacity (40-60% of those seeking treatment unable to access it), gaps in naloxone distribution, unsafe prescribing practices (particularly fentanyl prescribed without appropriate safeguards), lack of residential rehabilitation beds leading to unsafe discharge, and absence of real-time prescription monitoring. Key clinical lessons include the critical importance of naloxone availability, need for training in recognition of drug-seeking behaviour, inadequate pain management alternatives, and failings in coordinated care. The coroner emphasised that with evidence-based harm reduction strategies, including expanded supervised injection facilities, better prescriber education, and decriminalisation approaches, many of these deaths were preventable.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Specialties
Error types
Drugs involved
Contributing factors
- inadequate drug treatment capacity
- lack of naloxone availability
- unsafe opioid prescribing
- absence of real-time prescription monitoring
- lack of residential rehabilitation beds
- using drugs alone
- stigma reducing treatment access
- insufficient pain management alternatives
- absence of heroin substitution programs
- limited supervised injecting centres
Coroner's recommendations
- NSW Department of Premier and Cabinet facilitate and host a NSW Drug Summit with experts, parliamentarians, law enforcement, researchers, and drug users to develop evidence-based, human-rights focused drug policy
- Drug Summit should consider decriminalisation of personal drug use, ways to improve treatment, reduce stigma, expand non-pharmaceutical pain management, and improve family support
- Following Drug Summit, develop comprehensive 'whole of government' and 'whole of community' approach to illicit drug use
- NSW Health support immediate distribution of naloxone nasal spray to paramedics, police, GPs in high-prevalence areas, and emergency departments
- NSW Ambulance officers be trained to leave naloxone at overdose scenes
- Triple 0 operators receive training on advising callers to administer naloxone
- Expand ORTHN (Overdose Response and Take Home Naloxone) project including to rural areas
- Increase funding to harm reduction organisations like NUAA for distribution of naloxone in communities
- Urgent attention to introducing Real Time Prescribing (RTP) system in NSW including private scripts
- Urgent attention to improving affordability of drug substitution programs covering dispensing fees
- Consider alternative drug substitution programs for treatment-resistant users including low-dose mobile methadone, long-acting buprenorphine, and pharmaceutical heroin
- Consider additional medically supervised injection rooms (MSIR) in areas with high overdose rates and community support
- Support opiate monitoring programs at venues for public health planning
- Fund Family Drug Support and similar organisations to increase family and friend support services
- Study unmet need for drug treatment facilities and commit resources to increase facilities
- Increase availability of non-pharmaceutical pain management strategies including hydrotherapy, counselling, physiotherapy, mindfulness
- Develop plain speaking discharge summaries for persons admitted for drug-related conditions
- NSW Police consider providing naloxone nasal spray to officers for overdose treatment
- NSW Police receive training on naloxone use
- NSW Police consider training to leave naloxone at suspected overdose scenes
- NSW Police collect and consider data on involvement of opiates, particularly fentanyl, in overdose deaths
- Amend prescription drug legislation to allow family and friends to obtain naloxone on prescription and provide 'Good Samaritan' protections
- Review legislation governing authority to prescribe drugs of addiction to simplify wording and consider reclassifying fentanyl for stricter regulation
- RACGP develop training for GPs on vulnerable drug user care, risk assessment before prescribing painkillers, alternatives to prescription painkillers, and opioid/benzodiazepine prescribing guidelines
- Mandate training in RACGP as part of Continuing Professional Development requirements
- Pharmacy Guild develop educational activities on naloxone, safe use, stocking in community pharmacies, and availability of nasal spray
Full text
Related cases
Source and disclaimer
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —